| Dr Kenneth J Richter, DO | |
|
34505 West 12 Mile Rd Suite 100, Farmington Hills, MI 48331 | |
| (734) 343-7500 | |
| (312) 957-9991 |
| Full Name | Dr Kenneth J Richter |
|---|---|
| Gender | Male |
| Speciality | Neuromusculoskeletal Medicine, Sports Medicine |
| Location | 34505 West 12 Mile Rd Suite 100, Farmington Hills, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033159132 | NPI | - | NPPES |
| 2905041 TYPE 11 | Medicaid | MI |
| Entity Name | Oakland Physiatry, P.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457498081 PECOS PAC ID: 9638274467 Enrollment ID: O20070423000453 |
News Archive
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Twelve percent of adults in Sweden have diseases related to their use of medicines. But in four cases of ten it would have been possible to avoid the undesired effects.
› Verified 9 days ago
| Entity Name | Trinity Home Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508823774 PECOS PAC ID: 1951357672 Enrollment ID: O20180420002430 |
News Archive
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Twelve percent of adults in Sweden have diseases related to their use of medicines. But in four cases of ten it would have been possible to avoid the undesired effects.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth J Richter, DO 34505 West 12 Mile Rd Suite 100, Farmington Hills, MI 48331 Ph: (734) 343-7500 | Dr Kenneth J Richter, DO 34505 West 12 Mile Rd Suite 100, Farmington Hills, MI 48331 Ph: (734) 343-7500 |
News Archive
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
Twelve percent of adults in Sweden have diseases related to their use of medicines. But in four cases of ten it would have been possible to avoid the undesired effects.
› Verified 9 days ago